Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine-Reference-Cited by-同舟云学术

Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine

Published:2012-02 Issue:2 Volume:45 Page:810-820
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Ares-Santos S.,Granado N.,Oliva I.,O'Shea E.,Martin E.D.,Colado M.I.,Moratalla R.

Publisher

Elsevier BV

Subject

Neurology

Reference69 articles.

1. Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice;Achat-Mendes;Neuropsychopharmacology,2005

2. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents;Albers;J. Pharmacol. Exp. Ther.,1995

3. Methamphetamine-induced selective dopaminergic neurotoxicity is accompanied by an increase in striatal nitrate in the mouse;Anderson;Ann. N. Y. Acad. Sci.,2006

4. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum;Angulo;Ann. N. Y. Acad. Sci.,2004

5. Chronic microglial activation and progressive dopaminergic neurotoxicity;Block;Biochem. Soc. Trans.,2007

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methamphetamine and the brain: Emerging molecular targets and signaling pathways involved in neurotoxicity;Toxin Reviews;2024-06-04

2. Methamphetamine-induced encephalopathy in the absence of hyperammonemia;BMC Psychiatry;2023-04-20

3. Methamphetamine-induced encephalopathy in the absence of hyperammonemia;2023-01-04

4. Cannabidiol prevents methamphetamine-induced neurotoxicity by modulating dopamine receptor D1-mediated calcium-dependent phosphorylation of methyl-CpG-binding protein 2;Frontiers in Pharmacology;2022-09-06

5. Cannabidiol treatment prevents drug reinstatement and the molecular alterations evoked by amphetamine on receptors and enzymes from dopaminergic and endocannabinoid systems in rats;Pharmacology Biochemistry and Behavior;2022-07